Verrica Interim CFO John J. Kirby acquires $24,650 of common shares
VRCA•Interim CFO buys shares in open-market purchase
- Verrica Pharmaceuticals Interim CFO John J. Kirby bought 5,000 common shares in an open-market purchase.
- The shares were acquired at a weighted average price of $4.93.
- Kirby reported direct beneficial ownership of 23,962 common shares following the transaction.
